Related Experiment Video
Updated: May 28, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
The Correlation Between Plasma CACNA2D1 Protein Concentration and the Severity of Coronary Heart Disease
Le An1, Yanhui Ren1,2, Jin Yang3
1Department of Cardiology, Central Hospital of Dalian University of Technology, Dalian 116033, China.
Insights
Plasma CACNA2D1 protein concentration correlates with coronary artery stenosis severity. This finding suggests CACNA2D1 may serve as a novel biomarker for early coronary heart disease detection.
Area of Science:
- Cardiology
- Biomarker Discovery
- Protein Analysis
Background:
- Coronary heart disease (CHD) prevalence is increasing globally.
- Early detection methods for CHD are currently limited.
- Identifying novel biomarkers is crucial for timely diagnosis and intervention.
Purpose of the Study:
- To investigate the correlation between plasma CACNA2D1 protein concentration and the severity of coronary artery stenosis.
- To explore the potential of CACNA2D1 as a biomarker for coronary heart disease.
Main Methods:
- 267 inpatients undergoing coronary angiography were enrolled and categorized into four groups based on stenosis severity: minimal, mild, moderate, and severe.
- Baseline characteristics, clinical laboratory indicators, and plasma CACNA2D1 protein concentrations were measured and compared across groups.
- Statistical analyses were performed to determine correlations between CACNA2D1 levels and stenosis degree.
Main Results:
- Plasma CACNA2D1 protein concentration demonstrated a significant upward trend with increasing coronary artery stenosis severity.
- Concentrations ranged from 37.68 ng/mL in mild stenosis to 79.95 ng/mL in severe stenosis.
- A clear positive correlation was observed between plasma CACNA2D1 levels and the degree of coronary artery stenosis.
Conclusions:
- Plasma CACNA2D1 protein concentration is significantly correlated with the severity of coronary artery stenosis.
- CACNA2D1 shows potential as a valuable biomarker for assessing coronary artery stenosis and aiding in early CHD detection.
Objective:
The prevalence of coronary heart disease (CHD) continues to rise, and there is a lack of methods for early detection. To identify biomarkers for CHD, we analyzed the CACNA2D1 protein concentration in patients with different degrees of coronary artery stenosis to explore the correlation between plasma CACNA2D1 protein concentration and the severity of coronary artery stenosis.
Methods:
A total of 267 inpatients from the Department of Cardiology at Dalian Central Hospital who underwent coronary angiography were consecutively enrolled. According to the degree of stenosis, they were divided into four groups: minimal stenosis (70 cases), mild stenosis (68 cases), moderate stenosis (66 cases), and severe stenosis (63 cases). The baseline characteristics, clinical laboratory indicators, and CACNA2D1 protein concentration in blood samples of patients in each group were compared, and the correlations were analyzed.
Results:
As the degree of coronary artery stenosis worsened, plasma CACNA2D1 protein concentration in patients showed a gradual upward trend. The protein concentration was lowest in the mild stenosis group, at 37.68 ng/mL; it was 45.46 ng/mL in the mild-to-moderate stenosis group; it reached 55.22 ng/mL in the moderate stenosis group; and it was highest in the severe stenosis group, at 79.95 ng/mL.
Conclusion:
There is a correlation between plasma CACNA2D1 protein concentration and the degree of coronary artery stenosis, demonstrating that it has the potential to serve as a biomarker.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations